MAP3K7 and liver cancer: In addition, the hepatocyte-specific deletion of TAK1 in mice resulted in spontaneous hepatocyte death, inflammation, and fibrosis, which was partially prevented in a TNFR1-null background [7], leading to compensatory proliferation and fatal liver cancer via an NF-κB-independent pathway [8].